Cypress Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,095
Closed -$773K 139
2021
Q3
$773K Sell
6,095
-15
-0.2% -$2.18K 0.2% 97
2021
Q2
$1.02M Sell
6,110
-830
-12% -$134K 0.26% 89
2021
Q1
$1.26M Sell
6,940
-180
-3% -$41.8K 0.35% 81
2020
Q4
$1.42M Buy
7,120
+190
+3% +$38.6K 0.4% 76
2020
Q3
$1.52M Sell
6,930
-110
-2% -$23.3K 0.47% 68
2020
Q2
$1.34M Buy
7,040
+85
+1% +$14.9K 0.45% 71
2020
Q1
$1.08M Buy
6,955
+795
+13% +$92.5K 0.47% 68
2019
Q4
$516K Buy
+6,160
New +$469K 0.18% 104

Other funds holding TDOC

Cypress Asset Management's TDOC Position: Q4 2021 in Review

Cypress Asset Management sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 6,095 shares — an estimated $773K sold.

Cypress Asset Management first reported a position in TDOC in Q4 2019 and held it in 8 quarters. The position peaked at $1.52M in Q3 2020. 728 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Cypress Asset Management reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Cypress Asset Management sold 6,095 Teladoc Health shares in Q4 2021, an estimated $773K.
  • Cypress Asset Management first reported a position in Teladoc Health in Q4 2019 and held it in 8 quarters.
  • Cypress Asset Management's Teladoc Health position peaked at $1.52M in Q3 2020.
  • 728 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Cypress Asset Management's 13F filing for Q4 2021, filed 31 Jan 2022.